Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2019 | Association of HLA matching with outcome of UD-HSCT: EBMT study

Annalisa Ruggeri • 7 Dec 2019
ASH 2019
General Leukemia

Annalisa Ruggeri, MD, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, discusses a study from the Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT). This study analyzed the association of donor-recipient HLA matching with the clinical outcomes of unrelated donor hematopoietic stem cell transplantation (UD-HSCT). Dr Ruggeri reveals data from the study reinforces the importance of HLA matching in the setting of UD-HSCT, as the best HLA match resulted in better overall and leukemia-free survival. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

More from Annalisa Ruggeri

4:55
EBMT 2020: cellular therapy day
Annalisa Ruggeri • 31 Aug 2020
10:00
Graft failure after unmanipulated haplo-HSCT with PT-Cy in AML
Annalisa Ruggeri • 26 Aug 2020
3:39
HSCT with T-cell add-back of rivogenlecleucel in acute leukemia
Annalisa Ruggeri • 7 Dec 2019
2:26
abTCD haploidentical HSCT in pediatric AL: long-term outcomes
Annalisa Ruggeri • 7 Dec 2019

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
The content of VJHemOnc is intended for healthcare professionals